Related Experiment Video
Updated: Jul 6, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Verapamil-sensitive ventricular tachycardia in an infant
Christopher Snyder1, James Bishara, Rani Darling
1Ochsner Clinic Foundation-Pediatric Cardiology, New Orleans, LA 70121, USA. csnyder@ochsner.org
A rare infant ventricular tachycardia, unresponsive to standard treatments, was successfully managed with verapamil. This case highlights verapamil-sensitive tachycardia in infants, crucial for effective treatment.
Area of Science:
- Pediatric Cardiology
- Electrophysiology
- Neonatal Medicine
Background:
- Infantile tachycardia poses diagnostic and therapeutic challenges.
- Right bundle branch, superior axis ventricular tachycardia (VT) is uncommon in infants.
- Standard antiarrhythmic drugs and cardioversion are often ineffective.
Observation:
- A 6-month-old infant presented with rapid VT (197 bpm).
- The VT was refractory to adenosine, propranolol, flecainide, and amiodarone.
- Synchronized cardioversion also failed to terminate the arrhythmia.
Findings:
- Overdrive atrial pacing successfully terminated the tachycardia.
- Initiation of verapamil resulted in no recurrence of VT.
- This suggests a verapamil-sensitive mechanism for the tachycardia.
Implications:
- Verapamil-sensitive VT should be considered in infants with refractory VT.
- Prompt recognition and targeted therapy can prevent recurrent episodes.
- This case expands understanding of pediatric VT management.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
05:15Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias